Search results
Results from the WOW.Com Content Network
New antidepressants, like esketamine and brexanolone, have a fresh approach to treating depression and offer options when other medications may not work. Serotonin reuptake inhibitors...
The FDA has approved Auvelity, a new antidepressant that may treat symptoms faster than other medications. The drug may be especially effective for individuals with treatment-resistant depression. Auvelity joins ketamine as a potential new wave of faster-acting antidepressants.
The U.S. Food and Drug Administration on August 19 approved dextromethorphan-bupropion, or Auvelity, a drug used to treat major depressive disorder, also known as clinical depression, in...
In 2019, the FDA approved brexanolone (Zulresso) as the first drug specifically designed to treat moderate to severe postpartum depression (PPD). Experts consider some SSRIs safe to take...
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click...
A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine. The treatment, known as Stanford accelerated intelligent neuromodulation therapy (SAINT) or simply Stanford neuromodulation therapy, is an intensive ...
The Food and Drug Administration (FDA) in August approved Auvelity—an extended-release dextromethorphan/bupropion tablet—for the treatment of major depressive disorder in adults. This combination pill is the first FDA-approved oral antidepressant that does not primarily target the monoamine neurotransmitters serotonin, dopamine, and ...
The U.S. Food and Drug Administration (FDA) has approved gepirone ER, sold under the brand name Exxua, a first-in-class medication for the treatment of major depressive disorder (MDD),...
In August 2022, dextromethorphan-bupropion (Auvelity) was approved by the FDA to treat major depressive disorder in adults. Research suggests it works faster than a traditional...
Although psychosocial interventions might also be recommended, more effective treatments than those currently available are needed for people with moderate or severe depression. In the past 10 years, treatment trials have developed and tested many new targeted interventions.